Advanced search
Publication Cover
Expert Review of Vaccines Volume 10, 2011 - Issue 2
Submit an article Journal homepage
70
Views
13
CrossRef citations to date
0
Altmetric
Key Paper Evaluation

Induction of anti-tumor immunity and T-cell responses using nanodelivery systems engrafting TLR-5 ligand

Amulya K Panda National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi-110067, India. [email protected]
Pages 155-157 | Published online: 09 Jan 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Baofeng Cui, Xinsheng Liu, Yuzhen Fang, Peng Zhou, Yongguang Zhang & Yonglu Wang. (2018) Flagellin as a vaccine adjuvant. Expert Review of Vaccines 17:4, pages 335-349.
Read now

Articles from other publishers (12)

Chenchen Pei, Hu Dong, Zhidong Teng, Sumin Wei, Yun Zhang, Shuanghui Yin, Jianli Tang, Shiqi Sun & Huichen Guo. (2023) Self−Assembling Nanovaccine Fused with Flagellin Enhances Protective Effect against Foot−and−Mouth Disease Virus. Vaccines 11:11, pages 1675.
Crossref
Amina I. Makandar, Mannat Jain, Eiji Yuba, Gautam Sethi & Rajesh Kumar Gupta. (2022) Canvassing Prospects of Glyco-Nanovaccines for Developing Cross-Presentation Mediated Anti-Tumor Immunotherapy. Vaccines 10:12, pages 2049.
Crossref
Bhavika Gupta, Daizy Sadaria, Vaishnavi U. Warrier, Anuradha Kirtonia, Ravi Kant, Amit Awasthi, Prakash Baligar, Jayanta K. Pal, Eiji Yuba, Gautam Sethi, Manoj Garg & Rajesh Kumar Gupta. (2022) Plant lectins and their usage in preparing targeted nanovaccines for cancer immunotherapy. Seminars in Cancer Biology 80, pages 87-106.
Crossref
T. Sai Chaitanya, Sharvil Narendra Patil, Sayantani Ghosh, Jayanta K. Pal, Eiji Yuba & Rajesh Kumar Gupta. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges 349 396 .
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto & Patrícia Severino. (2020) Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials. Journal of Chemical Technology & Biotechnology 96:8, pages 2123-2140.
Crossref
Sandra Santos-Sierra. (2020) Developments in anticancer vaccination: budding new adjuvants. Biological Chemistry 401:4, pages 435-446.
Crossref
Vaishnavi U. Warrier, Amina I. Makandar, Manoj Garg, Gautam Sethi, Ravi Kant, Jayanta K. Pal, Eiji Yuba & Rajesh Kumar Gupta. (2019) Engineering anti-cancer nanovaccine based on antigen cross-presentation. Bioscience Reports 39:10.
Crossref
Rory C. F. De Brito, Jamille M. De O. Cardoso, Levi E. S. Reis, Joao F. Vieira, Fernando A. S. Mathias, Bruno M. Roatt, Rodrigo Dian D. O. Aguiar-Soares, Jeronimo C. Ruiz, Daniela de M. Resende & Alexandre B. Reis. (2018) Peptide Vaccines for Leishmaniasis. Frontiers in Immunology 9.
Crossref
Dora Hancz, Aniko Szabo, Tamás Molnar, Zsofia Varga, Aniko Hancz, Andrea Gregus, Anne-Odile Hueber, Eva Rajnavolgyi & Gabor Koncz. (2018) Flagellin increases death receptor-mediated cell death in a RIP1-dependent manner. Immunology Letters 193, pages 42-50.
Crossref
Evita Athanasiou, Maria Agallou, Spyros Tastsoglou, Olga Kammona, Artemis Hatzigeorgiou, Costas Kiparissides & Evdokia Karagouni. (2017) A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis. Frontiers in Immunology 8.
Crossref
Cleo Goyvaerts & Karine Breckpot. (2015) Pros and Cons of Antigen-Presenting Cell Targeted Tumor Vaccines. Journal of Immunology Research 2015, pages 1-18.
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology 135 178 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.